2022. IDENTIFICATION OF ENDOGENOUS SUPEROXIDE DISMUTASE AS A POTENTIAL INHIBITOR FOR PI3K/AKT SIGNALING IN COLORECTAL CANCER - A MOLECULAR DOCKING STUDY. Journal of Pharmaceutical Negative Results. (Oct. 2022), 1374–1379. DOI:https://doi.org/10.47750/pnr.2022.13.S03.214.